URGN — UROGEN PHARMA LTD
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
截至Q3 2026,共 173 家机构在其最新 13F 申报中持有 URGN(UROGEN PHARMA LTD),合计申报市值 $1.24B,对应 30.42M 股。按股数计算较上季度增持 3.7%(+988.76K 股),申报市值环比上升 14.5%。持仓集中度较高:前五大持有人占申报市值的 47.6%,前十大的集中度为 67.0%。
与上一季度相比,38 家新建仓位、64 家加仓、31 家减仓、60 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q3 2026 末的持仓状态,并非实时交易。
UROGEN PHARMA LTD(URGN)的主要机构持有人包括 RTW INVESTMENTS, LP、BlackRock Inc、Kynam Capital Management, LP,按 13F 申报市值在本页 333 家持有人中排名居前。
URGN 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
持有 URGN 的传奇投资人
我们追踪的超级投资人在各自最新 13F 申报中持有 URGN 的名单——每位投资人按其自身最近一个季度展示。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 173 | 30.42M | $1.24B | +4.0% |
| Q2 2026 | 194 | 43.27M | $1.59B | +0.5% |
| Q1 2026 | 178 | 46.80M | $841.17M | -9.1% |
| Q4 2025 | 175 | 45.91M | $1.06B | +2.9% |
| Q3 2025 | 169 | 45.07M | $891.92M | +8.3% |
| Q2 2025 | 153 | 37.54M | $508.53M | +2.7% |
| Q1 2025 | 142 | 42.48M | $465.81M | +6.5% |
| Q4 2024 | 142 | 37.26M | $392.52M | -11.8% |
表内 8 个季度中,机构持股合计减少 18%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2024(-11.8%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.54M | $184.62M | 1.86% | 持有 | |
| 3.11M | $126.29M | 0.00% | 减持 | |
| 2.43M | $98.90M | 5.48% | 持有 | |
| 2.20M | $89.37M | 1.64% | 持有 | |
| 2.17M | $88.36M | 0.01% | 减持 | |
| 1.65M | $66.98M | 18.40% | 减持 | |
| 1.38M | $55.88M | 0.02% | 减持 | |
| 1.15M | $46.67M | 5.95% | 减持 | |
| 975.79K | $39.65M | 0.00% | 增持 | |
| 770.91K | $31.32M | 0.19% | 持有 | |
| 750.20K | $30.48M | 2.75% | 增持 | |
| 617.51K | $25.09M | 0.00% | 增持 | |
| 500.73K | $20.34M | 0.06% | 持有 | |
| 462.07K | $18.77M | 0.00% | 增持 | |
| 406.30K | $16.51M | 0.02% | 增持 | |
| 369.79K | $15.02M | 0.82% | 增持 | |
| 348.12K | $14.14M | 0.08% | 新进 | |
| 305.22K | $12.40M | 0.02% | 增持 | |
| 303.19K | $12.32M | 0.00% | 持有 | |
| 297.08K | $12.07M | 0.77% | 新进 | |
| 295.62K | $12.01M | 0.27% | 新进 | |
| 287.22K | $11.67M | 0.02% | 新进 | |
| 266.22K | $10.82M | 0.00% | 增持 | |
| 240.82K | $9.78M | 0.00% | 增持 | |
| 235.85K | $9.58M | 0.00% | 减持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.54M | $90.65M | 1.12% | 持有 | |
| 4.22M | $84.11M | 2.81% | 新进 | |
| 3.19M | $63.65M | 0.29% | 持有 | |
| 2.58M | $51.50M | 0.00% | 增持 | |
| 2.53M | $50.44M | 0.00% | 增持 | |
| 2.20M | $43.88M | 0.54% | 增持 | |
| 1.58M | $31.47M | 4.46% | 减持 | |
| 1.51M | $30.20M | 0.01% | 增持 | |
| 1.26M | $25.13M | 12.76% | 持有 | |
| 1.16M | $23.09M | 0.08% | 增持 | |
| 1.15M | $22.99M | 0.12% | 持有 | |
| 1.00M | $19.95M | 0.77% | 持有 | |
| 888.93K | $17.73M | 0.04% | 增持 | |
| 888.93K | $17.73M | 0.01% | 增持 | |
| 819.45K | $16.35M | 0.00% | 增持 | |
| 770.91K | $15.38M | 0.17% | 持有 | |
| 717.35K | $14.31M | 0.70% | 新进 | |
| 689.00K | $13.75M | 0.35% | 增持 | |
| 687.48K | $13.72M | 0.05% | 新进 | |
| 679.00K | $13.55M | 0.68% | 减持 | |
| 575.00K | $11.47M | 3.66% | 持有 | |
| 534.54K | $10.66M | 0.00% | 增持 | |
| 507.53K | $10.13M | 0.00% | 增持 | |
| 471.23K | $9.40M | 0.00% | 持有 | |
| 424.92K | $8.48M | 0.00% | 增持 |
Q2 2025 — 25 家基金
新建仓(Q3 2026)
- Walleye Capital LLC 348.12K 股 · $14.14M
- NEXT CENTURY GROWTH INVESTORS LLC 297.08K 股 · $12.07M
- OBERWEIS ASSET MANAGEMENT INC/ 295.62K 股 · $12.01M
- Qube Research & Technologies Ltd 287.22K 股 · $11.67M
- Neo Ivy Capital Management 111.43K 股 · $4.53M
- Arrowstreet Capital 89.89K 股 · $3.65M
- Jump Financial, LLC 65.10K 股 · $2.65M
- RAYMOND JAMES FINANCIAL INC 60.15K 股 · $2.44M
- ExodusPoint Capital Management, LP 44.65K 股 · $1.81M
- BENDER ROBERT & ASSOCIATES 34.70K 股 · $1.41M
- JW Asset Management, LLC 20.00K 股 · $812.60K
- CenterBook Partners LP 15.80K 股 · $641.95K
完全清仓(较上季)
- SG Americas Securities, LLC 卖出 2.05M 股 · $75.55M
- Point72 Asset Management 卖出 1.53M 股 · $56.14M
- FRONTIER CAPITAL MANAGEMENT CO LLC 卖出 1.51M 股 · $55.51M
- Opaleye Management Inc. 卖出 1.44M 股 · $52.99M
- MENORA MIVTACHIM HOLDINGS LTD. 卖出 1.15M 股 · $42.41M
- D. E. Shaw & Co 卖出 1.15M 股 · $42.17M
- D. E. Shaw & Co., Inc. 卖出 1.15M 股 · $42.17M
- MPM BioImpact LLC 卖出 933.41K 股 · $34.35M
- Soleus Capital Management, L.P. 卖出 829.81K 股 · $30.54M
- Goldman Sachs Group 卖出 819.83K 股 · $30.17M
- ORBIMED ADVISORS LLC 卖出 676.19K 股 · $24.88M
- GEODE CAPITAL MANAGEMENT, LLC 卖出 610.36K 股 · $22.46M
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 4.54M | 4.54M | 4.54M | 4.54M | 4.54M | 4.54M | 3.83M | 3.83M | 3.79M | 3.56M | 3.26M | 1.73M | 857.46K | — | — | — | — | — | — | — |
| BlackRock Inc | 3.11M | 3.20M | 2.85M | 2.60M | 2.58M | 2.41M | 2.42M | 2.47M | 2.50M | — | — | — | — | — | — | — | — | — | — | — |
| Kynam Capital Management, LP | 2.43M | 2.43M | 2.25M | — | 282.41K | 656.57K | 25.00K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Jefferies Financial Group Inc. | 2.20M | 2.20M | 2.20M | 2.20M | 2.20M | 30.00K | 815.00K | 965.93K | 965.00K | 965.00K | 840.00K | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 2.17M | 2.58M | 2.56M | 2.56M | 2.53M | 2.48M | 857.73K | 767.30K | 2.18M | 1.84M | 390.55K | 455.12K | 111.13K | 62.95K | 143.46K | 49.15K | 45.01K | 83.28K | 39.89K | 22.37K |
| ACORN CAPITAL ADVISORS, LLC | 1.65M | 1.67M | 1.67M | 1.45M | 1.26M | 1.26M | 1.52M | 1.52M | — | — | — | — | — | — | — | — | — | — | — | — |
| AMERICAN CENTURY COMPANIES INC | 1.38M | 1.69M | 1.64M | 1.36M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.15M | 1.30M | 1.50M | 1.74M | 1.58M | 2.02M | 1.38M | 1.12M | 901.13K | 1.10M | 508.59K | 525.40K | 508.88K | — | — | — | — | — | — | — |
| STATE STREET CORP | 975.79K | — | 874.18K | 807.42K | 819.45K | 807.64K | 795.01K | 808.05K | 769.58K | 726.68K | 536.99K | 490.83K | 454.10K | — | — | — | — | — | — | — |
| Migdal Insurance & Financial Holdings Ltd. | 770.91K | 770.91K | 770.91K | 770.91K | 770.91K | 770.91K | 786.47K | 686.47K | 686.47K | 686.47K | 686.47K | 648.30K | 648.30K | — | — | — | — | — | — | — |
| Parkman Healthcare Partners LLC | 750.20K | 174.06K | 275.00K | 168.77K | 402.60K | 176.70K | 393.15K | 369.86K | 347.54K | 274.46K | 184.18K | 175.50K | 145.31K | — | — | — | — | — | — | — |
| Geode Capital Management | 617.51K | 610.36K | 523.83K | 475.21K | 471.23K | 470.73K | 473.33K | 461.90K | 455.64K | 421.39K | 323.95K | 312.52K | 219.13K | 201.72K | 14.38K | 14.38K | 14.38K | 14.38K | 176.21K | 167.76K |
| Woodline Partners LP | 500.73K | 500.73K | 500.73K | 500.73K | 306.37K | 306.72K | 306.37K | 305.64K | 305.64K | 303.74K | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 462.07K | 456.56K | 409.56K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Two Sigma Investments | 406.30K | 148.96K | 177.90K | 241.21K | 386.20K | 189.41K | 17.29K | 56.90K | 87.03K | 100.42K | 80.50K | 130.75K | 120.21K | 19.82K | — | — | — | — | — | — |
| ADAR1 Capital Management, LLC | 369.79K | 252.40K | 395.46K | 40.00K | 35.00K | 10.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Walleye Capital LLC | 348.12K | — | — | — | 190.45K | 346.16K | — | — | — | 57.61K | — | 27.22K | — | — | — | — | — | — | — | — |
| FEDERATED HERMES, INC. | 305.22K | 958 | — | 196 | 132 | — | — | — | — | — | — | 11.71K | 13.13K | — | — | — | — | — | — | — |
| Northern Trust Corp | 303.19K | 304.57K | 275.94K | 237.46K | 261.40K | 267.72K | 285.61K | 310.07K | 286.73K | 217.36K | 232.50K | 235.24K | 177.39K | 179.18K | 21.46K | 21.82K | 22.00K | 20.99K | 160.88K | 169.30K |
| NEXT CENTURY GROWTH INVESTORS LLC | 297.08K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold URGN?
As of 2026-Q3, 173 institutional funds reported holding URGN (UROGEN PHARMA LTD) in SEC 13F filings, with a combined reported value of $1.24B.
How many shares of URGN do institutions own?
13F filers reported 30.42M shares of URGN, worth $1.24B in aggregate at the end of 2026-Q3.
Is institutional ownership of URGN rising or falling?
Share counts moved +3.7% versus the prior quarter — accumulation.
Who are the top institutional holders of URGN?
The largest 13F holders are RTW INVESTMENTS, LP, BlackRock Inc, Kynam Capital Management, LP, Jefferies Financial Group Inc., Morgan Stanley; the top 25 are ranked at the top of this page.
Who are the major shareholders of UROGEN PHARMA LTD?
The major shareholders of UROGEN PHARMA LTD (URGN) by reported 13F value are RTW INVESTMENTS, LP, BlackRock Inc, Kynam Capital Management, LP, Jefferies Financial Group Inc., Morgan Stanley, among 333 institutional holders.
Which legendary investors own URGN?
2 of the legendary investors tracked on HoldingsHub report URGN (UROGEN PHARMA LTD) in their latest 13F filings, led by ARK Invest, Polen Capital Management. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on URGN?
2 tracked superinvestors hold URGN simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.